233 related articles for article (PubMed ID: 30396011)
1. Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Rufener R; Dick L; D'Ascoli L; Ritler D; Hizem A; Wells TNC; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):440-450. PubMed ID: 30396011
[TBL] [Abstract][Full Text] [Related]
2. Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
Stadelmann B; Rufener R; Aeschbacher D; Spiliotis M; Gottstein B; Hemphill A
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004535. PubMed ID: 26967740
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of the
Chaudhry S; Zurbriggen R; Preza M; Kämpfer T; Kaethner M; Memedovski R; Scorrano N; Hemphill A; Doggett JS; Lundström-Stadelmann B
Front Vet Sci; 2022; 9():981664. PubMed ID: 35990276
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.
Spicher M; Naguleswaran A; Ortega-Mora LM; Müller J; Gottstein B; Hemphill A
Exp Parasitol; 2008 Aug; 119(4):475-482. PubMed ID: 18442817
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis.
Liu C; Fan H; Ma J; Ma L; Ge RL
Parasit Vectors; 2021 Sep; 14(1):450. PubMed ID: 34488852
[TBL] [Abstract][Full Text] [Related]
6. Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.
Küster T; Stadelmann B; Aeschbacher D; Hemphill A
Int J Antimicrob Agents; 2014 Apr; 43(4):335-42. PubMed ID: 24646943
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
Liu C; Fan H; Guan L; Ge RL; Ma L
Parasit Vectors; 2021 Jul; 14(1):364. PubMed ID: 34256821
[TBL] [Abstract][Full Text] [Related]
8. The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
Lundström-Stadelmann B; Rufener R; Ritler D; Zurbriggen R; Hemphill A
Food Waterborne Parasitol; 2019 Jun; 15():e00040. PubMed ID: 32095613
[TBL] [Abstract][Full Text] [Related]
9. Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.
Stadelmann B; Scholl S; Müller J; Hemphill A
J Antimicrob Chemother; 2010 Mar; 65(3):512-9. PubMed ID: 20085998
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B; Rufener R; Hemphill A
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():121-129. PubMed ID: 32636148
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and in Vivo Effect of MAPK Signal Transduction Pathway Inhibitors on Echinococcus multilocularis.
Gui WF; Xu S; Dang ZS; Zhao YM
J Parasitol; 2019 Feb; 105(1):146-154. PubMed ID: 30807708
[TBL] [Abstract][Full Text] [Related]
13. Establishment and application of unbiased in vitro drug screening assays for the identification of compounds against Echinococcus granulosus sensu stricto.
Kaethner M; Preza M; Kaempfer T; Zumstein P; Tamponi C; Varcasia A; Hemphill A; Brehm K; Lundström-Stadelmann B
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011343. PubMed ID: 37540716
[TBL] [Abstract][Full Text] [Related]
14. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.
Rufener R; Ritler D; Zielinski J; Dick L; da Silva ET; da Silva Araujo A; Joekel DE; Czock D; Goepfert C; Moraes AM; de Souza MVN; Müller J; Mevissen M; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):331-340. PubMed ID: 29933218
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo.
Yuan M; Luo Y; Xin Q; Gao H; Zhang G; Jing T
Vet Parasitol; 2016 Aug; 226():38-43. PubMed ID: 27514881
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
17. Activity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells.
Hizem A; Lundström-Stadelmann B; M'rad S; Souiai S; Ben Jannet H; Flamini G; Ascrizzi R; Ghedira K; Babba H; Hemphill A
Parasitology; 2019 Jun; 146(7):956-967. PubMed ID: 30975235
[TBL] [Abstract][Full Text] [Related]
18. Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.
Ingold K; Bigler P; Thormann W; Cavaliero T; Gottstein B; Hemphill A
Antimicrob Agents Chemother; 1999 May; 43(5):1052-61. PubMed ID: 10223913
[TBL] [Abstract][Full Text] [Related]
19. Anti-echinococcal activity of menthol and a novel prodrug, menthol-pentanol, against Echinococcus multilocularis.
Fabbri J; Clemente CM; Elissondo N; Gambino G; Ravetti S; Hergert LY; Palma SD; Elissondo MC
Acta Trop; 2020 May; 205():105411. PubMed ID: 32101761
[TBL] [Abstract][Full Text] [Related]
20. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.
Siles-Lucas M; Casulli A; Cirilli R; Carmena D
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006422. PubMed ID: 29677189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
